Nasdaq:US$17.54 (-0.39) | HKEX:HK$27.08 (-0.60) | AIM:£2.50 (-0.1)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models